Life Science News

Latest updates from the biotech and pharma world

BioPharma Dive 2026-03-03

Kyowa Kirin abandons touted eczema drug following safety review

BioPharma Dive 2026-03-03

Pierre Fabre seeks to revive US approval chances for spurned cell therapy

BioPharma Dive 2026-03-02

Ascendis wins FDA approval of dwarfism drug

BioPharma Dive 2026-03-02

UniQure says FDA wants another study of Huntington’s gene therapy

BioPharma Dive 2026-03-02

Roche pill succeeds in another MS study, but approval questions linger

BioPharma Dive 2026-03-02

Candid, in a reverse merger with RallyBio, to go public

BioPharma Dive 2026-03-02

Safety concerns spur Aardvark to halt key Prader-Willi drug trial

BioPharma Dive 2026-03-02

Why it’s critical to close open steps in cell therapy manufacturing

BioPharma Dive 2026-02-27

Atrium spins out of Avidity, aiming to target rare heart diseases with RNA

BioPharma Dive 2026-02-27

UniQure falls further on Makary comments

BioPharma Dive 2026-02-27

Moderna’s combination flu, COVID shot wins over European drug regulators

BioPharma Dive 2026-02-27

Generate caps a strong month for biotech IPOs with $400M offering

BioPharma Dive 2026-02-26

Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial

BioPharma Dive 2026-02-26

Bristol Myers says ADC licensed from China hits mark in aggressive breast cancer

BioPharma Dive 2026-02-26

Boehringer drug approved in 44 days; BioMarin shelves Roctavian

BioPharma Dive 2026-02-26

Sarepta CEO Doug Ingram to retire, with company at a crossroads

BioPharma Dive 2026-02-25

Trump’s State of the Union trumpets healthcare greatest hits, but no new policies

BioPharma Dive 2026-02-25

Alkermes’ Richard Pops to step down after three-decade run as CEO

BioPharma Dive 2026-02-25

GSK to acquire 35Pharma in $950M deal for cardiovascular drug

BioPharma Dive 2026-02-25

15 states sue HHS over changes to childhood vaccine schedule

-2 / 13